These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 3520501)
1. Intravenous immunoglobulin in the treatment of neonatal sepsis: therapeutic strategies and laboratory studies. Fischer GW; Hemming VG; Hunter KW; Gloser H; Bachmayer H; Von Pilar CE; Helting T; Weisman LE; Wilson SR; Baron PA Pediatr Infect Dis; 1986; 5(3 Suppl):S171-5. PubMed ID: 3520501 [TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin therapy of neonatal group B streptococcal infections: an overview. Fischer GW Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S13-6. PubMed ID: 3041355 [TBL] [Abstract][Full Text] [Related]
3. Human immunoglobulins for intravenous use: comparison of available preparations for group B streptococcal antibody levels, opsonic activity, and efficacy in animal models. Givner LB Pediatrics; 1990 Dec; 86(6):955-62. PubMed ID: 2123536 [TBL] [Abstract][Full Text] [Related]
4. Intravenous gamma-globulin in the treatment of neonatal sepsis with special reference to group B streptococci and pharmacokinetics. Christensen KK; Christensen P Pediatr Infect Dis; 1986; 5(3 Suppl):S189-92. PubMed ID: 3520505 [No Abstract] [Full Text] [Related]
5. Pharmacokinetics of intravenous immunoglobulin (Sandoglobulin) in neonates. Weisman LE; Fischer GW; Hemming VG; Peck CC Pediatr Infect Dis; 1986; 5(3 Suppl):S185-8. PubMed ID: 3520504 [TBL] [Abstract][Full Text] [Related]
6. The role of specific antibody in neonatal bacterial infections: an overview. Anthony BF Pediatr Infect Dis; 1986; 5(3 Suppl):S164-7. PubMed ID: 3520499 [TBL] [Abstract][Full Text] [Related]
7. Opsonic and protective activity of immunoglobulin, modified immunoglobulin, and serum against neonatal Escherichia coli K1 infection. Bortolussi R; Fischer GW Pediatr Res; 1986 Feb; 20(2):175-8. PubMed ID: 3511443 [TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulin with high activity against group B streptococci. Gloser H; Bachmayer H; Helm A Pediatr Infect Dis; 1986; 5(3 Suppl):S176-9. PubMed ID: 3520502 [No Abstract] [Full Text] [Related]
9. Functional characteristics of a modified immunoglobulin preparation for intravenous administration: summary of studies of opsonic and protective activity against group B streptococci. Fischer GW; Wilson SR; Hunter KW J Clin Immunol; 1982 Apr; 2(2 Suppl):31S-35S. PubMed ID: 7045156 [TBL] [Abstract][Full Text] [Related]
10. Potential for intravenous gamma-globulin use in neonatal gram-negative infection: an overview. Bortolussi R Pediatr Infect Dis; 1986; 5(3 Suppl):S198-200. PubMed ID: 3520507 [No Abstract] [Full Text] [Related]
11. Polyvalent group B streptococcal immune globulin for intravenous administration: overview. Fischer GW; Hemming VG; Gloser HP; Bachmayer H; von Pilar CE; Wilson SR; Baron PA Rev Infect Dis; 1990; 12 Suppl 4():S483-9; discussion S489-91. PubMed ID: 2194273 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic intervention of clinical sepsis with intravenous immunoglobulin, white blood cells and antibiotics. Fischer GW; Weisman LE Scand J Infect Dis Suppl; 1990; 73():17-21. PubMed ID: 2128662 [TBL] [Abstract][Full Text] [Related]
13. Intravenous IgG in combination with other modalities in the treatment of neonatal infection. Hill HR; Shigeoka AO; Pincus S; Christensen RD Pediatr Infect Dis; 1986; 5(3 Suppl):S180-4. PubMed ID: 3520503 [No Abstract] [Full Text] [Related]
14. IgG subclasses and antibodies to group B streptococci in preterm neonates after intravenous infusion of immunoglobulin to the mothers. Morell A; Sidiropoulos D; Herrmann U; Christensen KK; Christensen P; Prellner K; Skvaril F Pediatr Infect Dis; 1986; 5(3 Suppl):S195-7. PubMed ID: 3520506 [No Abstract] [Full Text] [Related]
15. The opsonic antibody response of female rats to type III group B streptococcal immunization: a model for maternal immunity. Heiman HS; Weisman LE Vet Immunol Immunopathol; 1990 Jan; 24(1):79-89. PubMed ID: 2180204 [TBL] [Abstract][Full Text] [Related]
16. Comparison of group B streptococcal hyperimmune globulin and standard intravenously administered immune globulin in neonates. Weisman LE; Anthony BF; Hemming VG; Fischer GW J Pediatr; 1993 Jun; 122(6):929-37. PubMed ID: 8501574 [TBL] [Abstract][Full Text] [Related]
17. [Therapeutic effectiveness of an intravenous immunoglobulin with pH 4.25 in experimental neonatal sepsis caused by Klebsiella pneumoniae]. Mancilla-Ramírez J; Nurko-Shein S; Castellanos-Cruz C; Santos-Preciado JI Bol Med Hosp Infant Mex; 1989 Feb; 46(2):89-93. PubMed ID: 2496700 [TBL] [Abstract][Full Text] [Related]
18. Methods for evaluating the protective activity of intravenous immunoglobulins for neonatal pathogens: entanglement or encouragement? Baker CJ; Edwards MS Pediatrics; 1990 Dec; 86(6):995-7. PubMed ID: 2123537 [No Abstract] [Full Text] [Related]
19. [Maternal deficiency of IgG 2 and IgG 4 and neonatal infection caused by B-streptococci]. Maak B; Müller E; Berbig H; Estel C Zentralbl Gynakol; 1993; 115(3):136-9. PubMed ID: 8465627 [TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin in neonatal group B streptococcal disease. Pharmacokinetic and safety studies in monkeys and humans. Fischer GW; Weisman LB; Hemming VG; London WT; Hunter KW; Bosworth JM; Sever JL; Wilson SR; Curfman BL Am J Med; 1984 Mar; 76(3A):117-23. PubMed ID: 6424443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]